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Clinics and pathology 
Disease 
Therapy-related acute leukemia and myelodysplastic 
syndromes (MDS). 
Phenotype / cell stem origin 
M2-ANLL, acute monocytic leukemia, MDS, T-ALL. 
Etiology 
Latency from twenty months to six years after  
chemotherapy. 
Pathology 
inv(11) positive cells were detectable six years prior to 
apparent leukemia in one case. MLL-MAML2 positive 
cells were detectable up to two years prior to apparent 
leukemia in another case. Whole genome expression 
profiles demonstrated differential expression of both 
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Detection of MLL rearranged cell by fluorescence in situ 
 hybridization (FISH) with an MLL split signal probe. 
Genes involved and Proteins 
MAML2 
Location: 11q21 
DNA / RNA 
Spans 365 kb; 5 exons a major transcript of 7.5 kb. 
Protein 
1153 aa, 125 kDa; conserved N-terminal basic domain 
(aa 29-92) which binds to the ankyrin repeat domain of 
Notch receptors; two acidic domains (aa 263-360 and 




DNA / RNA 
21 exons, spanning over 100 kb; 13-15 kb mRNA. 
Protein 
3969 amino acids; 431 kDa; contains two DNA binding 
motifs: a AT hook homologous to high mobility group 
proteins HMGI-(Y) and HMGI(C) that binds to the 
minor groove of DNA, and zinc fingers, a DNA methyl 
transferase motif, a bromodomain, and segments of 
homology with trithorax, in particular in the C-terminal 
SET domain. 










Hybrid transcript MLL/MAML2 contains the following 
domains: 
- from MLL: AT-hook, DNA-Methyltransferase; 
- from MAML2: Q rich domain, acidic domain. 
Expression localisation 
In the nucleus. 
 
 






Atlas Genet Cytogenet Oncol Haematol. 2008;12(2)  165
References 
Obama K, Furukawa Y, Tara M, Niina K. Secondary monocytic 
leukemia with rearrangement of the MLL gene occurring during 
the course of adult T-cell leukemia. Int J Hematol 1998;68:323-
326. 
Metzler M, Zuna J, Stagee MS, Harder L, Meyer C, Flohr T, 
Meerpohl J, Fronkova E, Langer T, Harbott J, Trka J, Siebert 
R, Marschalek R, Niemeyer CM, Rascher W. Inv(11)(q21q23) 
fuses MLL to the NOTCH co-activator mastermind-like 2 in 
secondary T cell acute lymphoblastic leukemia. Blood (ASH 
Annual Meeting Abstracts) 2006;108:Abstract 4284. 
 
Takei N, Suzukawa K, Mukai HY, Itoh T, Okoshi Y, Yoda Y, 
Nagasawa T. Therapy-related acute myeloid leukemia 6 years 
after clonal detection of inv(11)(q21q23) and MLL gene 
rearrangement. Int J Hematol 2006;83(3):247-251. 
Nemoto N, Suzukawa K, Shimizu S, Shinagawa A, Takei N, 
Taki T, Hayashi Y, Kojima H, Kawakami Y, Nagasawa T. 
Identification of a novel fusion gene MLL-MAML2 in secondary 
acute myelogenous leukemia and myelodysplastic syndrome 
with inv(11)(q21q23). Genes Chromosomes Cancer 
2007;[Epub ahead of print]. 
This article should be referenced as such: 
Suzukawa K. inv(11)(q21q23) in therapy related leukemias. 
Atlas Genet Cytogenet Oncol Haematol. 2008;12(2):163-165.  
 
